13F

Stock

Neurocrine Biosciences Inc

NBIX · held by 5 managers

Reported value

$30.6M

Holders

5

+0 new · −0 exited

Holders’ est. mark

$16.4M

Price effect on 4 books still in the name

Largest holder

$25.2M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC337K$25.2M$17.3MAdded$5.54M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main49.9K$5.05M−$908.7KCut−$1.18M
Swiss Life Asset Management Ltd2.63K$266.5K−$45.8KCut−$34K
Leonteq Securities AG619$62.7K−$11.3KCut−$11.3K

Positions as of Q1 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.